AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
About the AMR Stakeholder Network
The Pharmaceutical Strategy is a chance to tackle antimicrobial resistance that Europe cannot miss says the MEP Interest Group on AMR
Members of the European Parliament from the MEP Interest Group on AMR and supporting MEPs call on the European Commission to ensure the proposed Pharmaceutical Strategy includes strong measures to tackle antimicrobial resistance
EPHA has joined with other health and environmental organisations calling for the development of a strong legislative framework to increase transparency throughout the entire pharmaceutical supply chain.
In response to the European Commission fitness check on animal welfare legislation, EPHA submitted the following response Animals are sentient beings and deserve the highest levels of protection. The assertion that the European Union (EU) has one of the world’s...
Analysis & Opinion
A packed room of key actors, including Health Commissioner Stella Kyriakides, committed to tackling Antimicrobial Resistance (AMR) from a One Health approach, joined MEPs for the launch of the MEP interest group on AMR which took place on 19 February 2020 in the...
A new MEP Interest Group on AMR in the European Parliament; EU action on AMR incentives; time for an international agreement on AMR? Our thoughts on what might happen in the year ahead.
Get the monthly EPHA AMR Feed!
AMR: setting the agenda for change Official launch of the MEP Interest Group on AMR
19 February 2020
Invest and Protect
7 May 2019
Joining the Dots
30 January 2018
Do you have a question?
Meet our AMR Policy Leads and Scientific Advisors.
+32 (0) 2 233 3877
Rose Gallagher MBE
EPHA Scientific Advisor on AMR
Professional Lead Infection Prevention & Control, Royal College of Nursing (UK)